Marshall Wace logo

Marshall Wace

Europe, England, United Kingdom, London

Description

Marshall Wace is a global asset manager that offers a diverse range of investors alternative investment solutions.

Investor Profile

Marshall Wace has made 61 investments, with 12 in the past 12 months and 26% as lead.

Stage Focus

  • Series B (21%)
  • Series C (21%)
  • Post Ipo Equity (16%)
  • Series E (11%)
  • Series Unknown (8%)
  • Series D (7%)
  • Series A (5%)
  • Private Equity (5%)
  • Series F (3%)
  • Seed (2%)

Country Focus

  • United States (77%)
  • India (8%)
  • Switzerland (5%)
  • United Kingdom (3%)
  • Canada (3%)
  • Singapore (2%)
  • Israel (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Financial Services
  • Fintech
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Life Science
  • Blockchain
  • Cryptocurrency
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Marshall Wace frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 9
venBio Partners
North America, California, United States, San Francisco
Co-Investments: 7
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 10
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 6
RTW Investments
North America, New York, United States, New York
Co-Investments: 8
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 10
BlackRock
North America, New York, United States, New York
Co-Investments: 6
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 8
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 10
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 11

Which angels does Marshall Wace often collaborate with?

Uday Kumar Bangalore Shivaraman
Asia, Karnataka, India, Bengaluru
Shared Deals: 1
PL
North America, California, United States, Palo Alto
Shared Deals: 1
FS
North America, California, United States, Santa Clara
Shared Deals: 1
AG
North America, New Jersey, United States, New Brunswick
Shared Deals: 1
EC
North America, California, United States, San Francisco
Shared Deals: 1
CC
North America, California, United States, San Jose
Shared Deals: 1
MS
North America, California, United States, San Francisco
Shared Deals: 1
BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Marshall Wace?

Sammaan Capital

Mumbai, Maharashtra, India

Sammaan Capital offers home loans in the affordable housing segment.

CreditFinancial ServicesLendingReal Estate
Post Ipo EquityJan 27, 2025
Amount Raised: $151,179,028
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
35Pharma

Montreal, Quebec, Canada

35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

BiopharmaBiotechnologyPharmaceutical
Series CNov 26, 2024
Amount Raised: $53,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

BiotechnologyDiabetesMedical Device
Series ENov 13, 2024
Amount Raised: $60,000,000
Inquis Medical

Redwood City, California, United States

Inquis Medical is developing thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss.

Health CareMedical
Series BNov 4, 2024
Amount Raised: $40,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Elektrofi

Boston, Massachusetts, United States

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Alternative MedicineBiotechnologyTherapeutics
Series CAug 22, 2024
Amount Raised: $112,250,000
Pathalys Pharma

Raleigh, North Carolina, United States

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

BiopharmaBiotechnology
Series BAug 20, 2024
Amount Raised: $105,000,000
Third Arc Bio

Boston, Massachusetts, United States

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

BiotechnologyHealth CareLife ScienceMedicalOncology
Series AJul 23, 2024
Amount Raised: $165,000,000
Human Interest

San Francisco, California, United States

Human Interest is a 401(k) provider that helps employees of small and medium-sized businesses save for retirement.

Employee BenefitsFinanceFinTechInsuranceInsurTechRetirementWealth Management
Series EJul 17, 2024
Amount Raised: $242,000,000